ADMA Biologics ADMA ADMA Bio Manufacturing — Sales & Marketing
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's adma bio manufacturing — sales & marketing.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's ADMA bio manufacturing — sales & marketing?
- ADMA Biologics (ADMA) reported ADMA bio manufacturing — sales & marketing of $7.2M in Q1 2026.
- How has ADMA Biologics's ADMA bio manufacturing — sales & marketing changed year-over-year?
- ADMA Biologics's ADMA bio manufacturing — sales & marketing increased by 19.1% year-over-year, from $6.04M to $7.2M.
- What is the long-term trend for ADMA Biologics's ADMA bio manufacturing — sales & marketing?
- Over 3 years (2022 to 2025), ADMA Biologics's ADMA bio manufacturing — sales & marketing has grown at a 25.1% compound annual growth rate (CAGR), from $13.67M to $26.74M.
- What does ADMA bio manufacturing — sales & marketing mean?
- Encompasses the costs incurred to promote, distribute, and sell the segment's biopharmaceutical products to healthcare providers and customers. This metric is a key indicator of the company's commercial reach and the effectiveness of its market penetration strategies.